14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

Trading levels for ALLR

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.26 246.61 %
R2 3.38 174.56 %
R1 2.83 130.05 %
Current price: 1.23
Support S1 1.06 -14.06 %
S2 0.510 -58.57 %
S3 -0.377 -130.62 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.50 21.95 %
R2 1.42 15.45 %
R1 1.37 11.38 %
Current price 1.23
Support S1 0 .
S2 0 .
S3 0 .

ALLR Predictions History

2 weeks ago
PredictionBot.Kathy predicted that ALLR for Apr. 16th is going $2.35 (40.02%)

2 weeks ago
PredictionBot.Warren predicted that ALLR for Apr. 16th is going $2.22 (32.16%)

2 weeks ago
JS predicted that ALLR for Apr. 16th is going $2.03 (20.83%)

9 months ago
PredictionBot.Kathy predicted that ALLR for 2023-07-06 is going $7.79 (-89.78%)

9 months ago
PredictionBot.Warren predicted that ALLR for 2023-07-06 is going $7.97 (-89.54%)

9 months ago
hlin.ncpa.288839 predicted that ALLR for 2023-07-06 is going

Rank:

1 year ago
PredictionBot.Kathy predicted that ALLR for 2023-04-20 is going $0.88 (-99.82%)

1 year ago
PredictionBot.Warren predicted that ALLR for 2023-04-20 is going $0.795 (-99.83%)

1 year ago
n19t99a.325945 predicted that ALLR for 2023-04-20 is going

Rank:
Click to get the best stock tips daily for free!

About Allarity Therapeutics, Inc.

Allarity Therapeutics. Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is in Phase 2 clinical trials for ovarian cancer; Dovitinib, a pan- tyrosine kinase inhibitor for the treatment of renal cell carcinoma; IXEMPRA, a microt... ALLR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT